1618942310 563

South Australian university reveals mRNA vaccine manufacturing plan

May 1, 2021

Published in Business Standard

Excerpts copied below. Read the full article in Business Standard at the link at the bottom of the page.

‘“Australia could achieve vaccine self-reliance within half a year after the University of Adelaide (UA) revealed a plan to manufacture mRNA vaccines.

The university on Wednesday announced a joint partnership with the South Australian Health and Medical Research Institute (SAHMRI) and international biotechnology company BioCina that could see it develop the capability to mass produce mRNA vaccines within six months.

Under the agreement, the Adelaide Pfizer plant purchased by BioCina in August 2020 would be used to manufacture vaccines with capital from the UA and the SAHMRI, the Xinhua news agency reported.”

“BioCina chief executive Ian Wisenberg said to The Australian: ‘In a country like Australia we are talking about 20 million people, or 40 million doses, which is not a lot in terms of production. We see no reason why we could not be producing 100 million doses within that same six to 12-month timeframe.’”

1 reply

Trackbacks & Pingbacks

  1. […] drugs from development to commercialization. Its work in pDNA plus its recent announcement for Covid-19 vaccine manufacturing is truly reflective of the promising future for BioCina,” says […]

Comments are closed.